SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Incyte (INCY)
An SI Board Since January 1996
Posts SubjectMarks Bans Symbol
3202 131 0 INCY
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3127Bullish crossover in MACD and Stochastic oscillator. [graphic]hollyhunter-4/17/2017
3126< If there's not much differentiation, first to market will be paramount.Miljenko Zuanic-4/15/2017
3125That is why CRL should be forwarded to the shareholder!Miljenko Zuanic-4/15/2017
3124Incyte has now got a huge clinical program for epacadosat, with PD-1 inhibitors tuck-4/14/2017
3123EMA Analysis of Baracitinib h/t to Peter. Neither he nor PGS can find anythintuck-4/14/2017
3122Ugh. finance.yahoo.comscaram(o)uche-4/14/2017
3121So far, StreetInsider is alone in calling the buyout of INCY by GILD. Certainlytuck-3/10/2017
3120Looks like they really wanted a piece of MCLA-134 (PD1/tim-3) or MCLA-145 (PDL1/scaram(o)uche-12/21/2016
3119Competing IDO programs. Rick parked a link to a study involving NewLink's Ituck15/12/2016
3118Thanks to a continuation of the bio-rally, and by a deal in which INCY gets rightuck-4/7/2016
3117Incyte is enjoying a bit of bounce today, challenging a tough resistance level. tuck-3/31/2016
3116I have been looking to buy INCY as well, sold my remaining shares in the 110 to Biotech Jim-3/24/2016
31156 years later we have RA BLA in EU...Yupyyyyy!!!! finance.yahoo.comMiljenko Zuanic-3/23/2016
3114~$54 million buy by Baker Bros in low $60s last week. Cheers, Tucktuck-3/23/2016
3113[graphic] Looks like it is the time to get in. hollyhunter-3/23/2016
3112Relative to Humira (I think) results are weak, at the best.Miljenko Zuanic-3/18/2016
3111Pfizer Announces Oral Tofacitinib, an Investigational JAK Inhibitor, Meets Primascaram(o)uche-3/18/2016
3110Bar looks like it's going up for injectables..... March 11, 2016 Sanofi anscaram(o)uche-3/11/2016
3109Inflammation, yes, T cell no??......... cancerdiscovery.aacrjournals.orgscaram(o)uche-3/10/2016
3108As you know by now, all solid cancer rux trials discontinued. Whiff in pancreatscaram(o)uche-2/11/2016
3107Bullish cross in MACD and Stochastic oscillator at foxchart. On watch.hollyhunter-2/2/2016
3106hemophagocytic lymphohistiocytosis..... https://www.stjude.org/media-resources/scaram(o)uche-1/29/2016
3105Ok, thanks, so are you saying the 3- breast cancer trial, which reads out next ~tuck-1/28/2016
3104The old trials, sure. They were single agent trials, designed to test for a dirscaram(o)uche-1/28/2016
3103">> another Jakafi whiff in cancer << Can you refresh my memortuck-1/28/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News